Discovering ARHGAP29: A Protein Involved in Cellular Signaling Pathways

Target Name: ARHGAP29

NCBI ID: G9411

ARHGAP29

Discovering ARHGAP29: A Protein Involved in Cellular Signaling Pathways

ARHGAP29 is a protein that is expressed in various tissues throughout the body, including muscle, heart, and brain. It is a member of the GTPase-activating protein (GAP) family, which includes proteins that play a crucial role in intracellular signaling pathways. The primary function of ARHGAP29 is to regulate the activity of the protein RhoGTPase, which is involved in the regulation of cell signaling pathways. In this article, we will discuss the discovery, function, and potential therapeutic applications of ARHGAP29 as a drug target and biomarker.

Discovery and Function

The GAP family of proteins plays a pivotal role in intracellular signaling pathways. These proteins are involved in the regulation of protein interactions, which are critical for the proper function of cells. The GAP-associated protein ARHGAP29 is a member of this family and is expressed in various tissues throughout the body.

ARHGAP29 is a 29 kDa protein that is expressed in muscle, heart, and brain. It is a critical regulator of the activity of RhoGTPase, which is a protein that is involved in the regulation of cell signaling pathways. RhoGTPase is a GTPase that is involved in the regulation of protein interactions, including the regulation of protein-protein interactions and protein-DNA interactions.

ARHGAP29 is involved in the regulation of RhoGTPase activity by interacting with its catalytic subunit. This interaction between ARHGAP29 and RhoGTPase allows for the regulation of the activity of RhoGTPase, which is involved in the regulation of cell signaling pathways. This interaction between ARHGAP29 and RhoGTPase is critical for the proper function of the cell.

In addition to its role in regulating RhoGTPase activity, ARHGAP29 is also involved in the regulation of cellular processes that are critical for the survival of the cell. For example, ARHGAP29 is involved in the regulation of cell adhesion, which is critical for the proper formation of tissues and organs.

Potential Therapeutic Applications

The discovery of ARHGAP29 as a drug target and biomarker has significant potential for the development of new therapeutic agents for various diseases. For example, ARHGAP29 has been shown to be involved in the regulation of cellular processes that are critical for the survival of the cell, making it an attractive target for therapeutic intervention.

ARHGAP29 has been shown to be involved in the regulation of cell adhesion, which is critical for the proper formation of tissues and organs. This makes it an attractive target for therapeutic intervention in diseases such as cancer, where the regulation of cell adhesion is disrupted.

In addition to its role in cell adhesion, ARHGAP29 is also involved in the regulation of cellular processes that are critical for the survival of the cell. This makes it an attractive target for therapeutic intervention in diseases such as neurodegenerative diseases, where the regulation of cellular processes is disrupted.

Conclusion

In conclusion, ARHGAP29 is a protein that is involved in the regulation of cellular processes that are critical for the survival of the cell. Its function as a regulator of the activity of RhoGTPase and its involvement in the regulation of cell adhesion make it an attractive target for therapeutic intervention in a variety of diseases. Further research is needed to fully understand the role of ARHGAP29 as a drug target and biomarker.

Protein Name: Rho GTPase Activating Protein 29

Functions: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Has strong activity toward RHOA, and weaker activity toward RAC1 and CDC42. May act as a specific effector of RAP2A to regulate Rho. In concert with RASIP1, suppresses RhoA signaling and dampens ROCK and MYH9 activities in endothelial cells and plays an essential role in blood vessel tubulogenesis

The "ARHGAP29 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARHGAP29 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets